|
Jan 9
|
Ambrx (AMAM) Skyrockets 102% on $2B Buyout Offer From J&J
|
|
Jan 9
|
Ambrx Holders Who Bought for Pennies See 6,700% Gain on J&J Bid
|
|
Jan 9
|
This Dividend Stock Has a $13 Billion Secret Weapon
|
|
Jan 2
|
Johnson & Johnson Announces Quarterly Dividend for First Quarter 2024
|
|
Jan 1
|
Meet the 2024 Dogs of the Dow
|
|
Dec 31
|
3 Beaten-Down Dow Jones Stocks That Dividend Investors Should Scoop Up in 2024
|
|
Dec 30
|
These are the largest publicly-traded companies in each US state
|
|
Dec 30
|
2 Best Warren Buffett Stocks to Buy for the Long Haul
|
|
Dec 29
|
UPDATE 1-Judge certifies Johnson & Johnson shareholder class action over talc disclosures
|
|
Dec 29
|
Judge certifies Johnson & Johnson shareholder class action over talc disclosures
|
|
Dec 29
|
REFILE-Judge certifies Johnson & Johnson shareholder class action over talc disclosures
|
|
Dec 29
|
There Are Only 5 Dow Stocks I Wouldn't Buy in 2024
|
|
Dec 29
|
11 Best Psychedelic Stocks to Buy in 2024
|
|
Dec 29
|
15 Best Dow Stocks To Buy Now
|
|
Dec 28
|
Johnson & Johnson (JNJ) Laps the Stock Market: Here's Why
|
|
Dec 28
|
11 Set-It-and-Forget-It Stocks to Buy According to Financial Media
|
|
Dec 28
|
Top 15 Value Stocks to Buy for 2024
|
|
Dec 28
|
Warren Buffett Dumped These 2 Top Dividend Stocks. Should You Follow His Lead?
|
|
Dec 28
|
11 Hot Healthcare Stocks To Buy Now
|
|
Dec 27
|
20 Most Expensive Drugs in the World
|